Histoplasmosis Complicating Tumor Necrosis Factor–α Blocker Therapy: A Retrospective Analysis of 98 Cases

Histoplasmosis After Solid Organ Transplant

(2013) M. Assi et al.   CLINICAL INFECTIOUS DISEASES

Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics?

(2012) Sengwee Toh et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Histoplasmosis infection in patients with rheumatoid arthritis, 1998-2009

(2011) Timothy C Olson et al.   BMC INFECTIOUS DISEASES

A Multicenter Evaluation of Tests for Diagnosis of Histoplasmosis

(2011) C. A. Hage et al.   CLINICAL INFECTIOUS DISEASES

Immune reconstitution syndrome and fungal infections

(2011) Ashish O. Gupta et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: A case series

(2010) Jennifer L. Dotson et al.   INFLAMMATORY BOWEL DISEASES

Improved Detection of Histoplasma Antigenemia following Dissociation of Immune Complexes

(2009) S. Swartzentruber et al.   Clinical and Vaccine Immunology

Recognition, Diagnosis, and Treatment of Histoplasmosis Complicating Tumor Necrosis Factor Blocker Therapy

(2009) Chadi A. Hage et al.   CLINICAL INFECTIOUS DISEASES

Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy

(2009) Sotirios Tsiodras et al.   MAYO CLINIC PROCEEDINGS